[Ultrastructural modifications induced by several drugs on adrenergic nerve endings and on the adrenal medulla].
D000313:Adrenal Medulla / Q000187:drug effects*; D000818:Animals; D001949:Bretylium Compounds / Q000494:pharmacology*; D002395:Catecholamines / Q000378:metabolism*; D006145:Guanethidine / Q000494:pharmacology*; D066298:In Vitro Techniques; D007490:Iproniazid / Q000494:pharmacology*; D008297:Male; D008854:Microscopy, Electron; D009411:Nerve Endings / Q000187:drug effects*; D010870:Pineal Gland / Q000187:drug effects / Q000294:innervation; D051381:Rats; D012110:Reserpine / Q000494:pharmacology*; D013564:Sympathetic Nervous System / Q000187:drug effects; D014649:Vas Deferens / Q000294:innervation
D001949:Bretylium Compounds; D002395:Catecholamines; D012110:Reserpine; D007490:Iproniazid; D006145:Guanethidine
Modifications ultrastructurelles provoquées par quelques médicaments sur les terminaisons nerveuses adrénergiques et sur la médullaire surrénale.